Stage III Non-Small Cell Lung Cancer AJCC v7

specific

Stage III includes: IIIA (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0) and IIIB (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1:

38

Centers

8

Active Trials

Cancer Funding

Top Centers for Stage III Non-Small Cell Lung Cancer AJCC v7(38)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
69.1
2
NCI Comprehensive
Active Research Program
69.1
3
NCI Comprehensive
Active Research Program
69.1
4
NCI Comprehensive
Active Research Program
69.1
5
Active Research Program
69.1
6
Active Research Program
69.1
7
Active Research Program
69.1
8
Active Research Program
69.1
9
NCI Comprehensive
46.6
10
NCI Comprehensive
46.6
11
NCI Comprehensive
46.6
12
NCI Comprehensive
46.6
1346.6
1446.6
15
NCI Comprehensive
46.6
1646.6
17
NCI Comprehensive
46.6
18
NCI Comprehensive
46.6
19
NCI Comprehensive
46.6
20
NCI Comprehensive
46.6
21
NCI Clinical
46.6
22
NCI Comprehensive
46.6
2346.6
24
NCI Comprehensive
46.6
2546.6
2646.6
2746.6
28
NCI Comprehensive
46.6
29
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
46.6
3046.6
3146.6
32
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
46.6
3346.6
3446.6
3546.6
3646.6
3746.6
3846.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →